PathogenDx
PrivateLast Round
Grant
Mar 1, 2021
Total Funding Raised
$12.56M
Company Overview
PathogenDx is a biotechnology company that provides a DNA-based pathogen testing platform for the cannabis, agriculture, food, and human diagnostics industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Quality Management, Biotech Equipment, Medical Devices, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PathogenDx Comps
Public and private peers based on sector, stage, and business model.
PathogenDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2021 | ||||
| Grant | Jul 28, 2020 | ||||
| Series B | Sep 30, 2019 | ||||
| Convertible Debt | Jul 17, 2018 |
Key People
Founding team and executive leadership
PathogenDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| Salveo Capital | Series B, Convertible Debt |
| NIH RADx | Grant |
| Altitude Investment Management | Series B, Convertible Debt |
| Flatiron Venture Partners | Series B |
| Advance Ventures | Series B |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2026
Announced new product at the International Production & Processing Expo.
- Jan 13, 2026
Launched Unified Salmonella Testing System at IPPE for the poultry industry.
PathogenDx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PathogenDx's valuation, stock price, and market status.
